Japanese Insurance Stock News

TSE:299A
TSE:299AMedia

Kurashiru (TSE:299A) Margin Stability And 32.6% TTM Earnings Growth Reinforce Bullish Narratives

Kurashiru (TSE:299A) has entered FY 2026 with Q3 revenue of ¥4.6b and basic EPS of ¥16.32, putting fresh numbers behind its recent run of reported growth forecasts and profitability metrics. Over the past few quarters, revenue has moved from ¥3.0b in FY 2025 Q2 to ¥3.6b in Q4 2025, then to ¥3.8b and ¥4.0b in FY 2026 Q1 and Q2 respectively, while basic EPS progressed from ¥9.54 to ¥9.55, ¥12.58 and ¥13.69 across the same periods, giving investors a steady series of top line and EPS reference...
TSE:9020
TSE:9020Transportation

A Look At East Japan Railway (TSE:9020) Valuation After Stronger Results And A Potential Dividend Increase

Earnings and dividend decisions move East Japan Railway into focus East Japan Railway (TSE:9020) is back on investors radar after reporting full year results to March 31, 2026, alongside a board meeting considering a dividend increase from retained earnings. See our latest analysis for East Japan Railway. The earnings announcement and proposed dividend increase have coincided with a sharp shift in sentiment, with the 1-day share price return of 9.21% lifting the share price to ¥3,700. This...
TSE:6454
TSE:6454Machinery

Assessing Max (TSE:6454) Valuation As Board Weighs Dividend And Share Buyback Decisions

Board meeting puts capital return plans in focus Max (TSE:6454) has called an April 30, 2026 board meeting to review a potential dividend increase, possible changes to its dividend policy, and decisions on acquiring its own shares. These topics go straight to how cash flows back to you as a shareholder. Any outcome from this meeting could influence how investors view Max’s income profile and capital allocation discipline. See our latest analysis for Max. At a share price of ¥1,796, Max has...
TSE:2160
TSE:2160Biotechs

Does First Phase 2/3 Pirfenidone Trial in Oncology Supportive Care Change The Bull Case For GNI Group (TSE:2160)?

GNI Group Ltd. announced that its consolidated subsidiary, Gyre Pharmaceuticals, has enrolled the first patient in a Phase 2/3 trial of its self-developed pirfenidone capsules (Etuary®) for radiation-induced lung injury with or without immune checkpoint inhibitor-related pneumonitis, following Chinese regulatory approval in March 2025. This step advances pirfenidone into oncology supportive care, targeting a serious complication of thoracic cancer treatment where current therapeutic options...
TSE:6952
TSE:6952Consumer Durables

A Look At Casio (TSE:6952) Valuation After Launch Of The New GBX H5600 G LIDE Watch

Casio Computer Ltd (TSE:6952) has drawn fresh attention after unveiling the GBX-H5600, the first G-LIDE watch with a heart rate monitor, expanded training metrics, and bio-based resin components aimed at performance and environmental considerations. See our latest analysis for Casio ComputerLtd. Despite the product launch, Casio ComputerLtd’s recent 7 day share price return of a 4.18% decline contrasts with its 30 day share price return of 8.15% and 1 year total shareholder return of 46.16%...
TSE:7911
TSE:7911Commercial Services

Does TOPPAN Holdings (TSE:7911) HAPS Pivot Hint At A Deeper Strategic Reinvention?

In April 2026, SoftBank Corp. announced it had jointly developed with TOPPAN Holdings a new ultra-light, durable wing skin and testing method for solar High-Altitude Platform Station (HAPS) aircraft, designed to withstand extreme stratospheric UV, ozone and temperature conditions for longer operational periods. This collaboration extends TOPPAN’s advanced multi-layer film and weather-resistance technologies into stratospheric communications infrastructure, opening potential applications in...
TSE:4578
TSE:4578Pharmaceuticals

Did Stronger Q1 2026 Profitability Just Shift Otsuka Holdings' (TSE:4578) Investment Narrative?

In April 2026, Otsuka Holdings Co., Ltd. reported first-quarter 2026 results showing sales of ¥630,342 million and net income of ¥98,348 million, both higher than the same period a year earlier, with basic earnings per share from continuing operations rising to ¥186.31. This combination of higher sales, stronger net income, and improved earnings per share suggests the company converted top-line growth into more efficient profitability in the quarter. We’ll now examine how this stronger...
TSE:6971
TSE:6971Electronic

Kyocera (TSE:6971) Margin Rebuild To 6.8% Challenges Prolonged Bearish Profitability Narrative

Kyocera (TSE:6971) has wrapped up FY 2026 with fourth quarter revenue of ¥548.2 billion and basic EPS of ¥32.42, against a current share price of ¥2,746.5, putting hard numbers around a year that saw earnings bounce strongly and margins reset. Over the past six reported quarters, the company has seen quarterly revenue range from ¥478.0 billion to ¥548.2 billion while basic EPS moved from ¥4.09, through a loss equivalent of ¥12.60 per share, to ¥32.42, backed by trailing twelve month EPS of...
TSE:4206
TSE:4206Chemicals

A Look At Aica Kogyo Company (TSE:4206) Valuation After Record Earnings And Higher Dividend

Aica Kogyo Company (TSE:4206) drew investor focus after reporting record highs in net sales and profits for the fiscal year, along with another increase in its annual dividend and a higher payout forecast. See our latest analysis for Aica Kogyo Company. The record earnings, higher dividend and upbeat outlook come after a mixed year in the market, with a modest 1-year total shareholder return of 4.06% alongside a 3-year total shareholder return of 29.70%, hinting at momentum that has cooled...
TSE:8058
TSE:8058Trade Distributors

Mitsubishi (TSE:8058) Is Up 5.4% After Profit Dips Despite Higher Sales And Asset Sale Plan

Mitsubishi Corporation has released its full-year results for the period ended March 31, 2026, reporting sales of ¥18.92 trillion and net income of ¥800.46 billion, both slightly higher sales but lower profit than the previous year. The earnings report also showed a reduction in basic earnings per share from continuing operations to ¥210.92, highlighting pressure on profitability despite revenue growth. We’ll now examine how this weaker earnings profile, alongside the planned sale of...
TSE:9412
TSE:9412Media

Assessing SKY Perfect JSAT (TSE:9412) Valuation As Dividend Board Meeting Nears

Dividend decision puts SKY Perfect JSAT in focus SKY Perfect JSAT (TSE:9412) has called a board meeting for 28 April 2026 to consider dividends from retained earnings for the fiscal year ended 31 March 2026, a key point for income focused investors. See our latest analysis for SKY Perfect JSAT. Investor attention around the dividend decision comes after a strong run in the shares, with a 30 day share price return of 16.58% and a year to date gain of 73.24%, while the 1 year total shareholder...
TSE:9001
TSE:9001Transportation

Tobu Railway’s Valuation After Board Meeting Plans Dividend Forecast Revision

Board meeting puts Tobu Railway’s dividend policy in focus Tobu Railway (TSE:9001) has called an April 30, 2026 board meeting to consider revising its year end dividend forecast, a move that puts shareholder payouts and capital allocation firmly on investors’ radar. See our latest analysis for Tobu Railway. The share price has risen in the short term, with a 1 day share price return of 2.31% and a 7 day share price return of 2.97%. The 1 year total shareholder return of 9.43% contrasts with a...
TSE:7981
TSE:7981Building

Takara Standard (TSE:7981) Margin Improvement Reinforces Bullish Earnings Narratives

Takara StandardLtd (TSE:7981) has wrapped up FY 2026 with fourth quarter revenue of ¥60.1 billion and Basic EPS of ¥37.38, while trailing twelve month revenue stood at ¥252.8 billion and EPS at ¥231.88, alongside earnings growth of 35.9% over the last year. Over recent periods, revenue has ranged from ¥59.1 billion to ¥69.5 billion per quarter, with quarterly EPS moving between ¥30.28 and ¥89.68, giving investors a clear view of how the top line and per share earnings have tracked into the...
TSE:2692
TSE:2692Consumer Retailing

Itochu Shokuhin (TSE:2692) Q4 Loss And 1.1% Margin Pressure Test Bullish Narratives

ITOCHU-SHOKUHIN (TSE:2692) has wrapped up FY 2026 with fourth quarter revenue of ¥161.9b and a basic EPS loss of ¥46.35, against a trailing twelve month EPS of ¥652.09 on revenue of ¥720.2b that came with 0.8% earnings growth and a 1.1% net margin over the period. Over recent quarters, revenue has ranged from ¥175.1b in Q1 2026 to ¥192.5b in Q3 2026, while quarterly EPS has moved between ¥196.10 and ¥292.35 before the latest quarterly loss. This leaves investors to weigh a solid full year...
TSE:9110
TSE:9110Shipping

One‑Off ¥7.0b Gain Driving NS United Kaiun Kaisha (TSE:9110) Margin Story Challenges Bulls

NS United Kaiun Kaisha (TSE:9110) has just posted its FY 2026 numbers, with fourth quarter revenue of ¥58,520 million and basic EPS of ¥252.15, rounding out a year in which trailing twelve month EPS reached ¥1,022.47 on revenue of ¥229,784 million and earnings growth of 29.4%. Over the last year, the company has seen net profit margin move from 7.5% to 10.5%, while trailing twelve month net income excluding extra items reached ¥24,095 million, supported by a ¥7.0b one off gain that is front...
TSE:8103
TSE:8103Trade Distributors

Meiwa (TSE:8103) Margin Slip To 2% Tests Bullish High Quality Earnings Narrative

Latest FY 2026 Results Set the Stage for Meiwa's Next Chapter Meiwa (TSE:8103) closed FY 2026 with fourth quarter revenue of ¥43.1b and basic EPS of ¥29.85, rounding out a year where trailing twelve month revenue reached ¥164.9b and EPS came in at ¥83.98. Over recent periods, revenue has moved from ¥156.7b on a trailing basis in FY 2025 to ¥164.9b in FY 2026, while trailing EPS has shifted from ¥83.27 to ¥83.98. This gives investors a clear view of how top line and per share profitability...
TSE:2413
TSE:2413Healthcare Services

The Bull Case For M3 (TSE:2413) Could Change Following Strong FY2026 Results And Capital Return Boost

M3, Inc. held a board meeting on May 1, 2026, alongside releasing fiscal 2026 results that showed double-digit revenue and profit growth, a higher annual dividend, and new plans for share repurchases under its Articles of Incorporation. The company also issued an upbeat forecast for fiscal 2027, projecting revenue of ¥400.0 billion and profit attributable to owners of the parent of ¥53.0 billion, underscoring management’s confidence in its healthcare-related digital services model. Next, we...
TSE:3349
TSE:3349Consumer Retailing

Assessing COSMOS Pharmaceutical (TSE:3349) Valuation After Sales Growth, Steady Outlook And Higher Dividend

Why COSMOS Pharmaceutical’s latest update matters for shareholders COSMOS Pharmaceutical (TSE:3349) reported 7.7% sales growth with modest profit gains for the nine months to February 2026, maintained its full year forecast, and flagged an annual dividend increase to ¥75. See our latest analysis for COSMOS Pharmaceutical. The latest earnings and dividend news comes after a weaker period for the share price, with a 30 day share price return of 8.34% and a year to date share price return...
TSE:4221
TSE:4221Chemicals

Okura Industrial (TSE:4221) Margin Decline To 4.5% Tests Bullish Earnings Growth Narrative

Okura Industrial Q1 2026 earnings snapshot Okura Industrial (TSE:4221) opened its Q1 2026 scorecard with revenue of ¥24.0b and basic EPS of ¥130.49, setting the tone for how the year is starting at a share price of ¥4,910. Over recent quarters the company has seen revenue move from ¥21.7b in Q1 2025 to ¥22.4b in Q4 2025 and now ¥24.0b, while basic EPS has ranged from ¥108.47 to ¥130.49 over the same span. This gives a clear sense of how the top and bottom line are tracking into this latest...
TSE:7731
TSE:7731Consumer Durables

Assessing Nikon (TSE:7731) Valuation After The APDIS MV5X Laser Radar Launch

Nikon (TSE:7731) is drawing investor attention after the commercial launch of its APDIS MV5X Laser Radar system, which uses Aeva’s Eve sensor technology under a multi-year production agreement for automated inspection and metrology. See our latest analysis for Nikon. The APDIS MV5X announcement arrives as Nikon’s share price shows mixed short term momentum, with a 7 day share price return of 7.49% contrasting with a 30 day share price return decline of 8.40%. The 1 year total shareholder...
TSE:7733
TSE:7733Medical Equipment

Is FDA Clearance Of POWERSEAL Open Extended Jaw Reshaping The Investment Case For Olympus (TSE:7733)?

In April 2026, Olympus Corporation received FDA 510(k) clearance in the U.S. for its single-use POWERSEAL Open Extended Jaw Sealer/Divider, expanding its POWERSEAL surgical portfolio across multiple specialties including general, gynecological, colorectal, bariatric, urological, thoracic, and vascular surgery. This clearance broadens Olympus’s advanced energy offering with an open-surgery device designed for confident vessel sealing up to 7mm, multifunctional jaw capabilities, and ergonomics...
TSE:6135
TSE:6135Machinery

Makino Milling Machine (TSE:6135) Margin Improvement To 8% Tests Bullish Profitability Narratives

Makino Milling Machine (TSE:6135) has wrapped up FY 2026 with fourth quarter revenue of ¥71,052 million and basic EPS of ¥297.67, while trailing twelve month revenue sits at ¥261,184 million and EPS at ¥897.47. Over the past six reported quarters, revenue has ranged from ¥55,397 million to ¥71,052 million per quarter and basic EPS has moved between ¥53.32 and ¥310.67, providing a view of how the top and bottom line have tracked into the latest result. Net profit margin was reported at 8%...
TSE:4519
TSE:4519Pharmaceuticals

Do Chugai Pharmaceutical’s (TSE:4519) Strong Q1 Earnings And New Stock Plan Reframe Its Incentives Story?

Chugai Pharmaceutical Co., Ltd. reported first-quarter 2026 results with sales of ¥291,577 million, revenue of ¥321,747 million, and net income of ¥115,418 million, all higher than a year earlier. The board also moved to introduce a trust-based stock compensation system, highlighting how governance and incentive design are evolving alongside the company’s earnings profile. We’ll now examine how this strong first-quarter earnings growth shapes Chugai Pharmaceutical’s investment narrative and...
TSE:8015
TSE:8015Trade Distributors

Toyota Tsusho (TSE:8015) Margin Compression Tests Bullish Profitability Narratives

Toyota Tsusho (TSE:8015) has wrapped up FY 2026 with fourth quarter revenue of ¥3.2t and basic EPS of ¥79.13, supported by trailing twelve month revenue of ¥11.6t and EPS of ¥350.95 that frame the latest print in a broader context of steady throughput. Over the past six reported quarters, revenue has moved from ¥2.6t in FY 2025 Q3 to ¥3.2t in FY 2026 Q4, while quarterly EPS has ranged between ¥79.13 and ¥94.76, giving you a clear view of how the top and bottom line have tracked together as...